Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04624178
Title A Study of Rucaparib and Nivolumab in People With Leiomyosarcoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

leiomyosarcoma

Therapies

Nivolumab + Rucaparib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.